Combatting infectious diarrhea: innovations in treatment and vaccination strategies

Vivek P Chavda1, Suneetha Vuppu2, Toshika Mishra2

  • 1Department of Pharmaceutics and Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad, Gujarat, India.

Expert Review of Vaccines
|February 19, 2024
PubMed

Insights

Infectious diarrhea is a major global health issue, particularly in developing nations. This review explores management strategies, focusing on novel vaccine development and delivery methods to combat this serious childhood illness.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Infectious diarrhea presents a significant public health challenge, especially in developing countries, leading to high mortality rates in young children.
  • The condition encompasses acute, invasive, acute bloody, and chronic diarrhea, caused by diverse pathogens including bacteria, viruses, protozoans, and helminths.

Purpose of the Study:

  • To review the current landscape of infectious diarrhea, including its types and management approaches.
  • To extensively discuss preventive, therapeutic, and vaccination strategies for infectious diarrhea.
  • To explore advancements in vaccine development, delivery methods, and future research directions.

Main Methods:

  • Literature review of infectious diarrhea, its classification, and causative agents.
  • Analysis of current and emerging vaccination strategies, including advantages and limitations.
  • Exploration of novel vaccine development approaches and immunization routes.

Main Results:

  • Infectious diarrhea remains a critical health concern with various pathogenic causes.
  • Vaccination strategies are a key component of management, with ongoing research into improved vaccines.
  • Innovative delivery methods like nasal sprays and plant-based vaccines show promise for cost-effectiveness and wider accessibility.

Conclusions:

  • Effective management of infectious diarrhea requires a multi-faceted approach, integrating prevention, therapy, and vaccination.
  • Continued research into novel vaccine technologies and alternative delivery systems is crucial for global health.
  • Future studies should focus on identifying persistent pathogens and optimizing treatment outcomes.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
119
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
170
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Vaccinations01:51

Vaccinations

Overview
44.5K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
145